Investing

Tenaya Therapeutics : TNYA

TNYA

Stock Data

$0.71

$0.01 (2.13%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Based in South San Francisco, California, Tenaya Therapeutics is at the forefront of biotechnology with a focus on developing innovative therapies for heart disease. Leveraging cutting-edge platforms in cellular regeneration, gene therapy, and precision medicine, Tenaya is working on a range of treatments. These include gene therapies for specific types of cardiomyopathy and a small molecule for heart failure, alongside pioneering efforts in cardiac regeneration to help patients recover from heart failure caused by myocardial infarction. Founded in 2016, Tenaya aims to transform the landscape of cardiovascular disease treatment.

All Tenaya Therapeutics Articles

4 Articles

Trey Thoelcke | Apr 2, 2025 at 8:45 AM EDT

Insiders Are Loving These 5 Tech and Biotech Stocks

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with…

Trey Thoelcke | Mar 11, 2025 at 8:45 AM EDT

Insiders Are Loading Up on These 4 Biotech Stocks Now

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks…

Joshua Rodriguez | Jul 30, 2024 at 8:49 AM EDT

5 Penny Stocks With 250% Upside in 1 Year According to Wall Street

Penny stocks represent an interesting investment opportunity. These stocks typically represent small companies or companies that are early in the…

Trey Thoelcke | Feb 18, 2024 at 11:20 AM EST

Insider Buying: Taking a Controlling Stake in a Struggling Retailer?

A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted…